Literature DB >> 28334641

Humanized mouse model for assessing the human immune response to xenogeneic and allogeneic decellularized biomaterials.

Raymond M Wang1, Todd D Johnson1, Jingjin He2, Zhili Rong2, Michelle Wong1, Vishal Nigam3, Atta Behfar4, Yang Xu5, Karen L Christman6.   

Abstract

Current assessment of biomaterial biocompatibility is typically implemented in wild type rodent models. Unfortunately, different characteristics of the immune systems in rodents versus humans limit the capability of these models to mimic the human immune response to naturally derived biomaterials. Here we investigated the utility of humanized mice as an improved model for testing naturally derived biomaterials. Two injectable hydrogels derived from decellularized porcine or human cadaveric myocardium were compared. Three days and one week after subcutaneous injection, the hydrogels were analyzed for early and mid-phase immune responses, respectively. Immune cells in the humanized mouse model, particularly T-helper cells, responded distinctly between the xenogeneic and allogeneic biomaterials. The allogeneic extracellular matrix derived hydrogels elicited significantly reduced total, human specific, and CD4+ T-helper cell infiltration in humanized mice compared to xenogeneic extracellular matrix hydrogels, which was not recapitulated in wild type mice. T-helper cells, in response to the allogeneic hydrogel material, were also less polarized towards a pro-remodeling Th2 phenotype compared to xenogeneic extracellular matrix hydrogels in humanized mice. In both models, both biomaterials induced the infiltration of macrophages polarized towards a M2 phenotype and T-helper cells polarized towards a Th2 phenotype. In conclusion, these studies showed the importance of testing naturally derived biomaterials in immune competent animals and the potential of utilizing this humanized mouse model for further studying human immune cell responses to biomaterials in an in vivo environment.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biocompatibility; Cardiac tissue engineering; Extracellular matrix (ECM); Immune response; Macrophage; Scaffold

Mesh:

Substances:

Year:  2017        PMID: 28334641      PMCID: PMC5434867          DOI: 10.1016/j.biomaterials.2017.03.016

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  56 in total

Review 1.  Biomaterials for the treatment of myocardial infarction: a 5-year update.

Authors:  Aboli A Rane; Karen L Christman
Journal:  J Am Coll Cardiol       Date:  2011-12-13       Impact factor: 24.094

Review 2.  Macrophage polarization comes of age.

Authors:  Alberto Mantovani; Antonio Sica; Massimo Locati
Journal:  Immunity       Date:  2005-10       Impact factor: 31.745

3.  Xenogeneic extracellular matrix grafts elicit a TH2-restricted immune response.

Authors:  A J Allman; T B McPherson; S F Badylak; L C Merrill; B Kallakury; C Sheehan; R H Raeder; D W Metzger
Journal:  Transplantation       Date:  2001-06-15       Impact factor: 4.939

4.  Macrophage phenotype as a determinant of biologic scaffold remodeling.

Authors:  Stephen F Badylak; Jolene E Valentin; Anjani K Ravindra; George P McCabe; Ann M Stewart-Akers
Journal:  Tissue Eng Part A       Date:  2008-11       Impact factor: 3.845

Review 5.  Designing regenerative biomaterial therapies for the clinic.

Authors:  E Thomas Pashuck; Molly M Stevens
Journal:  Sci Transl Med       Date:  2012-11-14       Impact factor: 17.956

6.  Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction.

Authors:  Jennifer M Singelyn; Priya Sundaramurthy; Todd D Johnson; Pamela J Schup-Magoffin; Diane P Hu; Denver M Faulk; Jean Wang; Kristine M Mayle; Kendra Bartels; Michael Salvatore; Adam M Kinsey; Anthony N Demaria; Nabil Dib; Karen L Christman
Journal:  J Am Coll Cardiol       Date:  2012-02-21       Impact factor: 24.094

7.  T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease.

Authors:  Francesco Boin; Umberto De Fanis; Susan J Bartlett; Fredrick M Wigley; Antony Rosen; Vincenzo Casolaro
Journal:  Arthritis Rheum       Date:  2008-04

Review 8.  Xenogeneic extracellular matrix as a scaffold for tissue reconstruction.

Authors:  Stephen F Badylak
Journal:  Transpl Immunol       Date:  2004-04       Impact factor: 1.708

9.  An effective approach to prevent immune rejection of human ESC-derived allografts.

Authors:  Zhili Rong; Meiyan Wang; Zheng Hu; Martin Stradner; Shengyun Zhu; Huijuan Kong; Huanfa Yi; Ananda Goldrath; Yong-Guang Yang; Yang Xu; Xuemei Fu
Journal:  Cell Stem Cell       Date:  2014-01-02       Impact factor: 24.633

10.  Xenogeneic skin graft rejection is especially dependent on CD4+ T cells.

Authors:  R N Pierson; H J Winn; P S Russell; H Auchincloss
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

View more
  15 in total

Review 1.  Decellularized Extracellular Matrix Materials for Cardiac Repair and Regeneration.

Authors:  Donald Bejleri; Michael E Davis
Journal:  Adv Healthc Mater       Date:  2019-02-04       Impact factor: 9.933

Review 2.  Extracellular matrix hydrogel therapies: In vivo applications and development.

Authors:  Martin T Spang; Karen L Christman
Journal:  Acta Biomater       Date:  2017-12-20       Impact factor: 8.947

3.  Distinct release strategies are required to modulate macrophage phenotype in young versus aged animals.

Authors:  Daniel Hachim; Aimon Iftikhar; Samuel T LoPresti; Alexis L Nolfi; Shweta Ravichandar; Clint D Skillen; Bryan N Brown
Journal:  J Control Release       Date:  2019-05-17       Impact factor: 9.776

4.   Extracellular Matrix-Based Biomaterials and Their Influence Upon Cell Behavior.

Authors:  Madeline C Cramer; Stephen F Badylak
Journal:  Ann Biomed Eng       Date:  2019-11-18       Impact factor: 3.934

5.  Injectable hydrogels of optimized acellular nerve for injection in the injured spinal cord.

Authors:  R Chase Cornelison; Elisa J Gonzalez-Rothi; Stacy L Porvasnik; Steven M Wellman; James H Park; David D Fuller; Christine E Schmidt
Journal:  Biomed Mater       Date:  2018-03-21       Impact factor: 3.715

6.  In vivo evaluation of bioprinted cardiac patches composed of cardiac-specific extracellular matrix and progenitor cells in a model of pediatric heart failure.

Authors:  Donald Bejleri; Matthew J Robeson; Milton E Brown; Jervaughn Hunter; Joshua T Maxwell; Benjamin W Streeter; Olga Brazhkina; Hyun-Ji Park; Karen L Christman; Michael E Davis
Journal:  Biomater Sci       Date:  2022-01-18       Impact factor: 6.843

Review 7.  A Review on Properties of Natural and Synthetic Based Electrospun Fibrous Materials for Bone Tissue Engineering.

Authors:  Deval Prasad Bhattarai; Ludwig Erik Aguilar; Chan Hee Park; Cheol Sang Kim
Journal:  Membranes (Basel)       Date:  2018-08-14

8.  Evaluation of the biocompatibility and stability of allogeneic tissue-engineered cartilage in humanized mice.

Authors:  Emeline Perrier-Groult; Eléonore Pérès; Marielle Pasdeloup; Louis Gazzolo; Madeleine Duc Dodon; Frédéric Mallein-Gerin
Journal:  PLoS One       Date:  2019-05-20       Impact factor: 3.240

9.  Dermal Extracellular Matrix-Derived Hydrogels as an In Vitro Substrate to Study Mast Cell Maturation.

Authors:  Emily W Ozpinar; Ariana L Frey; Greer K Arthur; Camilo Mora-Navarro; Andreea Biehl; Douglas B Snider; Glenn Cruse; Donald O Freytes
Journal:  Tissue Eng Part A       Date:  2020-11-19       Impact factor: 4.080

10.  Can We Grow Valves Inside the Heart? Perspective on Material-based In Situ Heart Valve Tissue Engineering.

Authors:  Carlijn V C Bouten; Anthal I P M Smits; Frank P T Baaijens
Journal:  Front Cardiovasc Med       Date:  2018-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.